ArticleCureus2026
Trapped in the Trabeculae: A Rare Case of Noncompaction Cardiomyopathy and Large Left Ventricular Thrombus.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Left ventricular noncompaction (LVNC) is a rare primary cardiomyopathy characterized by a failure of myocardial morphogenesis, resulting in a prominent, characteristic "sponge-like" trabeculated endocardial layer. Clinical presentation is classical for heart failure, ventricular arrhythmias, and systemic thromboembolism, which defines its severity. Here, we describe a 34-year-old male with no prior medical history who presented with progressive dyspnea and volume overload. On initial evaluation, severe biventricular failure, stage 3b chronic kidney disease (type 2 cardiorenal syndrome), and significant hemodynamic impairment were noted. Subsequently, contrast-enhanced transthoracic echocardiography (TTE) was consistent with the diagnosis of LVNC and identified multiple mural thrombi, including a 2 cm mobile apical thrombus. Coronary angiography revealed normal coronary anatomy. Following these findings, the patient was stabilized with intravenous diuretics and initiated on guideline-directed medical therapy (GDMT). Due to the high risk of sudden cardiac death and persistent low ejection fraction, he was discharged with a wearable cardioverter defibrillator and referred for advanced heart failure and transplant evaluation. Shifting focus to the underlying pathophysiology, thrombus formation in LVNC is unique. It goes beyond global systolic dysfunction; the deep intertrabecular recesses create stasis that predisposes to fibrin deposition regardless of wall motion. This thrombogenicity necessitates a nuanced approach to anticoagulation. In summary, LVNC should be a primary consideration in young patients presenting with new-onset heart failure. This case underscores the necessity of imaging to identify obscured thrombi and highlights the evolving role of direct oral anticoagulants (DOACs) in managing the specific mechanical risks inherent to noncompacted myocardium.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.